Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Camu Camu Pilot Study
NCT04058392Phase 1Completed
- Sponsor
- McGill University Health Centre
- Start
- Nov 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in human immunodeficiency virus infection (HIV), sponsored by McGill University Health Centre. Primary endpoint: Lipopolysaccharide at 12 weeks. Started Nov 2020; status: completed.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04058392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04058392.